Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Schulz

Showing results (81-90 of 185) with videos related to

Pageof 19
Sort By:
Eye and Brain|November 19, 2024
Peripapillary Retinal Nerve Fiber Layer (pRNFL) Thickness - A Novel Biomarker of Neurodegeneration in Late-Infantile CLN2 DiseaseNikolaos Gkalapis, Simon Dulz, Carsten Grohmann, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2002
Aminoglycoside pretreatment partially restores the function of truncated V(2) vasopressin receptors found in patients with nephrogenic diabetes insipidusAngela Schulz, Katrin Sangkuhl, Thomas Lennert, et al.
Physiological Genomics|November 24, 2011
Induction of albuminuria and kidney damage in SHR by transfer of chromosome 8 from Munich Wistar Frömter ratsAngela Schulz, Sabrina Schütten-Faber, Nicole van Es, et al.
Physiological Genomics|August 7, 2008
Genetic predisposition for glomerulonephritis-induced glomerulosclerosis in rats is linked to chromosome 1Daphne H T Ijpelaar, Angela Schulz, Joris Aben, et al.
Acta Ophthalmologica|October 6, 2023
Genetic risk of glaucoma is associated with vascular and retinal nerve fibre wedge defectsDanit G Saks, Angela Schulz, Ayub Qassim, et al.
Journal of Child Neurology|February 5, 2021
Development of the "Hamburg Best Practice Guidelines for ICV-Enzyme Replacement therapy (ERT) in CLN2 Disease" Based on 6 Years Treatment Experience in 48 PatientsChristoph Schwering, Gertrud Kammler, Eva Wibbeler, et al.
BMC Molecular Biology|June 26, 2008
Off-target effects of siRNA specific for GFPCordula Tschuch, Angela Schulz, Armin Pscherer, et al.
Plos One|December 29, 2016
Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein ReceptorVera Lede, Christin Franke, Andrej Meusel, et al.
AJNR. American Journal of Neuroradiology|July 8, 2024
Enzyme Replacement Therapy for CLN2 Disease: MRI Volumetry Shows Significantly Slower Volume Loss Compared with a Natural History CohortPritika Gaur, Paul Gissen, Asthik Biswas, et al.
Neuropediatrics|June 17, 2023
Language Delay in Patients with CLN2 Disease: Could It Support Earlier Diagnosis?Miriam Nickel, Paul Gissen, Rebecca Greenaway, et al.
Pageof 19

Showing results (81-90 of 185) with videos related to

Sort By:
Pageof 19
Eye and Brain|November 19, 2024
Peripapillary Retinal Nerve Fiber Layer (pRNFL) Thickness - A Novel Biomarker of Neurodegeneration in Late-Infantile CLN2 DiseaseNikolaos Gkalapis, Simon Dulz, Carsten Grohmann, et al.
The Journal of Clinical Endocrinology and Metabolism|November 5, 2002
Aminoglycoside pretreatment partially restores the function of truncated V(2) vasopressin receptors found in patients with nephrogenic diabetes insipidusAngela Schulz, Katrin Sangkuhl, Thomas Lennert, et al.
Physiological Genomics|November 24, 2011
Induction of albuminuria and kidney damage in SHR by transfer of chromosome 8 from Munich Wistar Frömter ratsAngela Schulz, Sabrina Schütten-Faber, Nicole van Es, et al.
Physiological Genomics|August 7, 2008
Genetic predisposition for glomerulonephritis-induced glomerulosclerosis in rats is linked to chromosome 1Daphne H T Ijpelaar, Angela Schulz, Joris Aben, et al.
Acta Ophthalmologica|October 6, 2023
Genetic risk of glaucoma is associated with vascular and retinal nerve fibre wedge defectsDanit G Saks, Angela Schulz, Ayub Qassim, et al.
Journal of Child Neurology|February 5, 2021
Development of the "Hamburg Best Practice Guidelines for ICV-Enzyme Replacement therapy (ERT) in CLN2 Disease" Based on 6 Years Treatment Experience in 48 PatientsChristoph Schwering, Gertrud Kammler, Eva Wibbeler, et al.
BMC Molecular Biology|June 26, 2008
Off-target effects of siRNA specific for GFPCordula Tschuch, Angela Schulz, Armin Pscherer, et al.
Plos One|December 29, 2016
Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein ReceptorVera Lede, Christin Franke, Andrej Meusel, et al.
AJNR. American Journal of Neuroradiology|July 8, 2024
Enzyme Replacement Therapy for CLN2 Disease: MRI Volumetry Shows Significantly Slower Volume Loss Compared with a Natural History CohortPritika Gaur, Paul Gissen, Asthik Biswas, et al.
Neuropediatrics|June 17, 2023
Language Delay in Patients with CLN2 Disease: Could It Support Earlier Diagnosis?Miriam Nickel, Paul Gissen, Rebecca Greenaway, et al.
Pageof 19